Article

Biomarker Discovery for Early Detection of Hepatocellular Carcinoma (HCC)in Hepatitis C (HCV) Infected Patients.

University of Texas Medical Branch, United States
Molecular &amp Cellular Proteomics (Impact Factor: 7.25). 09/2013; DOI: 10.1074/mcp.M113.031252
Source: PubMed

ABSTRACT Chronic hepatic disease damages the liver, and the resulting wound healing process lead to liver fibrosis and subsequent development of cirrhosis. The leading causes of hepatic fibrosis and cirrhosis is infection with hepatitis C virus (HCV), and of the patients with HCV-induced cirrhosis 2to5% develop Hepatocellular carcinoma (HCC) with survival rate of 7%. HCC is one of the leading causes of cancer related deaths worldwide and the poor survival rate is largely due to late stage diagnosis making successful intervention difficult if not impossible. The lack of sensitive and specific diagnostic tools, and urgent need for early stage diagnosis, prompted us to discover new candidate biomarkers for HCV and HCC. We used aptamer based fractionation technology to reduce serum complexity, differentially labeled samples (6 HCC, 6 HCV) with fluorescent dyes, and resolved proteins in pair-wise 2D-DIGE. DeCyder software was used to identify differentially expressed proteins, spots picked, and MALDI/MS/MS used to identify that ApoA1 was down regulated by 22% (p<0.004) in HCC compared to HCV. Differential expression quantified by 2D DIGE was confirmed by 18O/16O stable isotope differential labeling with LC/MS/MS zoom scans. Technically independent confirmation was demonstrated by triple quadrupole LC/MS/MS selected reaction monitoring (SRM) assays with three peptides specific to human ApoA1 (DLATVYVDVLK, WQEEMELYR, VSFLSALEEYTK) using 18O/16O labeled samples and further verified with AQUA peptides as internal standards for quantification. In 50 patient samples (24 HCV and 26 HCC), all three SRM assays yielded highly similar differential expression of ApoA1 in HCC and HCV patients. These results validated the SRM assays which were independently confirmed by western blotting. Thus, ApoA1 is a candidate member of a SRM biomarker panel for early diagnosis, prognosis, and monitoring of HCC. Future, multiplexing of SRM assays for other candidate biomarkers is envisioned to develop a biomarker panel for subsequent verification and validation studies.

2 Followers
 · 
201 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanotechnology has been one of the major success stories of the early 21st century. The foundation for this success rests on the discovery that a small size confers completely new properties on materials. Nowadays, engineered nanomaterials (ENMs) are used in a plethora of applications such as paints, cosmetics, food products and electronics. These new properties, however, potentially make ENMs more reactive in biological systems than their large-scale counterparts. Already, asbestos-like effects have been described in mice after exposure to certain forms of carbon nanotubes (CNTs), while nano-sized titanium dioxide (nTiO2) has been shown to evoke inflammation in mouse lung. Therefore, extensive nanosafety studies have to be performed to ensure that no adverse effects are suffered by either workers or end-users of ENM products. This thesis has investigated health effects of ENMs by proteomic methods, first by evaluating the uptake and interactions of ENMs with plasma and cellular proteins followed by an analysis of the effects of ENM exposure on the intracellular proteome and secretome of human primary macrophages. The results revealed that ENM interactions with cellular proteins were governed by the surface reactivity of ENMs, whereas interactions with plasma proteins seemed to depend on the combination of both surface reactivity and active recognition, namely tagging of ENMs by opsonin proteins. The binding of cellular proteins to ENMs and subsequent interference with cellular processes might represent a novel cause of ENM toxicity, especially since transmission electron microscopy (TEM) micrographs indicated that several ENM species could be visualized free in the cytoplasm. The cytoplasmic protein expression changes after exposure to silica coated and uncoated nTiO2 revealed that silica coated TiO2 induced stronger protein expression changes in the macrophages. Most of the proteins with altered expression were related to phagocytosis, oxidative stress and inflammation. These proteome changes indicate that macrophages are actively engulfing ENMs and processing them. Moreover, the up-regulation of oxidative stress related proteins might be an indication of oxidative burst. Finally, nTiO2 treatment evoked acetylation of cytoplasmic proteins, a previously uncharacterized phenomenon in cells exposed to ENMs. The results from the macrophage secretome analysis showed that asbestos and long rigid carbon nanotubes (R CNTs) produced a similar response, while protein secretion profile of macrophages exposed to long tangled carbon nanotubes (T CNTs) exhibited a distinct profile. Bioinformatic analysis revealed that R CNTs evoked secretion of inflammation and apoptosis related proteins, possibly because of lysosomal damage. Functional assay confirmed that R CNT exposure triggered apoptosis in macrophages, while T CNTs and asbestos did not. This thesis offers new knowledge concerning the biological effects of engineered nanomaterials. Proteomic methods proved to be useful in the ENM protein interaction studies revealing that it would be beneficial to include the ENM-protein interaction experiments as part of the routine ENM characterization when assessing the health effects of ENMs. By employing quantitative proteomics, we obtained a global view of both cytoplasmic and secreted proteome changes of macrophages exposed to different ENMs.
    04/2014; Unigrafia., ISBN: 978-952-10-9809-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives Osteosarcoma (OS) is one of the most common primary malignant bone tumours of childhood and adolescence, and is characterized by high propensity for metastasis (specially to the lung), which is the main cause of death. However, molecular mechanisms underlying metastasis of OS are still poorly understood.Materials and methodsMetadherin (MTDH) was identified to be significantly upregulated in OS tissues that had metastasized compared to OS without metastasis, using a two-dimensional approach of electrophoresis, coupled with mass spectrometry. To understand the function of MTDH in OS, OS cell lines U2OS and SOSP-M were transfected with retroviral shRNA vector against MTDH.ResultsIt was found that metastatic propensity as well as cell proliferation were significantly reduced in both U2OS and SOSP-M. Migration and invasion of U2OS and SOSP-M cells were significantly lower after knock-down of MTDH. In addition, epithelial–mesenchymal transition (EMT) was reduced after knock-down of MTDH. Clinicopathologically, overexpression of MTDH was significantly associated with metastasis and poor survival of patients with OS.Conclusion Taken together, our results demonstrate that MTDH mediated metastasis of OS through regulating EMT. This could be an ideal therapeutic target against metastasis of OS.
    Cell Proliferation 08/2014; 47(5). DOI:10.1111/cpr.12129 · 3.28 Impact Factor

Full-text

Download
119 Downloads
Available from
May 16, 2014